ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her primary specialty after we conducted our analysis. The updated address appears on this page.

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,078Medicare Part D Prescriptions Filled, Including Refills
$1.64M Total Retail Price of All Prescriptions
644 Patients Receiving at Least One Drug in Part D
18%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 5,824 1,097 S3 10
OXYCODONE HCL 2,711 327 S2 10
CARISOPRODOL 2,266 216 R 10
MORPHINE SULFATE ER 1,213 78 S2
METHADONE HCL 1,087 121 S2
ENDOCET 714 108 S2
KETOPROFEN 630 103 10
LYRICA 586 94
GABAPENTIN 539 74
LIDOCAINE-PRILOCAINE 532 96 10
OXYCONTIN 459 72 S2
FENTANYL 434 69 S2
PROMETHAZINE HCL 395 48 R
CELEBREX 322 96
ZOLPIDEM TARTRATE 292 39
CYCLOBENZAPRINE HCL 288 25 R
OXYCODONE HCL-ACETAMINOPHEN 271 15 S2
METHOCARBAMOL 250 17 R
HYDROMORPHONE HCL 216 34 S2
TRAMADOL HCL 214 51
MELOXICAM 212 59
OPANA ER 186 0 S2
MORPHINE SULFATE 162 23 S2
TIZANIDINE HCL 149 13
AMITRIPTYLINE HCL 107 17 R
FLECTOR 97 27
CYMBALTA 95 41
NUCYNTA ER 92 0 S2 10
NIFEDIAC CC 91 22
TOPIRAMATE 85 0
PRISTIQ ER 84 0
VOLTAREN 76 25
OXYCODONE-ACETAMINOPHEN 75 14 S2
TRAZODONE HCL 67 0
NUCYNTA 63 24 S2
LIDODERM 63 18
BACLOFEN 59 0
ROPINIROLE HCL 59 24
AVINZA 56 0 S2
LUNESTA 54 0
DRONABINOL 52 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.